These emerging medications , including Rybelsus, belong to a group of drugs called GLP-1 receptor agonists . Primarily intended for treating diabetes mellitus , they function by encouraging the pancreas to release sufficient insulin and limiting high blood sugar levels. Furthermore , their potent